Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
about
ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activityCHMP4B, a novel gene for autosomal dominant cataracts linked to chromosome 20qSERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by NefLate assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis.The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activityHIV type 1 Gag as a target for antiviral therapyA role for ubiquitin ligase recruitment in retrovirus releaseRelease of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 buddingPotent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding siteBending out and breaking away: host-cell accomplices in retroviral escapeHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchNucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cellsStructure and Dynamics of Full-Length HIV-1 Capsid Protein in SolutionStructure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopyCryo-electron microscopy of tubular arrays of HIV-1 Gag resolves structures essential for immature virus assemblyA PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus buddingTy3 capsid mutations reveal early and late functions of the amino-terminal domainThe Life-Cycle of the HIV-1 Gag-RNA ComplexThe interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assemblyEfficient production of HIV-1 virus-like particles from a mammalian expression vector requires the N-terminal capsid domainESCRT-independent budding of HIV-1 gag virus-like particles from Saccharomyces cerevisiae spheroplastsMutation of the TYTLE motif in the cytoplasmic tail of the sendai virus fusion protein deeply affects viral assembly and particle productionCrystal structure of an HIV assembly and maturation switch.Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesThe structural biology of HIV assembly.Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells.Endosomal trafficking of HIV-1 gag and genomic RNAs regulates viral egress.Viral determinants of polarized assembly for the murine leukemia virus.Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.The nucleocapsid domain of Gag is dispensable for actin incorporation into HIV-1 and for association of viral budding sites with cortical F-actin.Cytoplasmic HIV-1 RNA is mainly transported by diffusion in the presence or absence of Gag proteinAnalysis of the initiating events in HIV-1 particle assembly and genome packagingRhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction.Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes.HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral buddingEffect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.PIV5 M protein interaction with host protein angiomotin-like 1Novel approaches to inhibiting HIV-1 replication.
P2860
Q24318462-72CF7F0E-6F42-4722-9633-599E3C539A14Q24337564-1296A6C2-1F29-44F8-928B-A71F12A50987Q24338889-2008650B-E7C7-478B-A5CA-39BE3912757FQ24540052-A2F0A6E8-0A86-4FB8-B619-92CD026C971BQ24596322-AC8164EC-E95D-42E3-8D56-994C5446FECEQ24614498-AED8B25C-D701-471E-BDAE-2B0EC52CED22Q24642874-A95B4F93-A287-4756-BD7B-8EFFB0069470Q24677985-E1509A2E-7C98-4A0E-94CC-F443A7459E5FQ24683048-7C3E1870-780E-4F11-9298-1F81825B2448Q24799632-6242568E-A7E1-45C6-BD5D-EE53543D85C8Q26746070-86BC1211-0FE6-413B-B50F-C4D50CD238B4Q27312753-9DB4C003-6D87-4C43-9649-C88EF56669F8Q27680056-2906EF91-9C93-4329-89AE-D96D3BE2171CQ27681296-D92295BF-ADE9-4430-87BC-AA0867501F07Q27683857-4A304BA8-A06D-40DA-85DF-DCE08FF8E5D0Q27863679-8830498D-79AD-46A0-91B2-645013D8B4E4Q27931343-452CE5D8-D352-478D-96A8-E280657409C3Q28076985-D9AC5AE5-FB4A-4D09-970E-EA637B5B94AEQ28205104-3D10E02B-9394-4F6A-A9B7-30FFF0D583B1Q28478202-528EDBD3-EB00-4CBF-A5B8-44658828F8BBQ28484533-BE4ED19F-0BE2-4FF3-B06D-11EF6F250D84Q28536684-3278BB59-04B6-472A-B13F-9CB21FD888CEQ30276365-1EB1F705-3C6A-4FEF-AB8F-09BDE0F6A3C2Q30332833-6714575D-CE07-4DEC-B9AC-D16F419602D2Q30437103-E2BC1BB2-9EF1-4E66-8626-76118B00F82FQ30479297-A2555F6E-BEDC-4B3E-AA54-937D55889BCAQ30490064-FBC6D983-86AF-40C6-9859-1E7C9B52DA77Q30503126-1EF91BEC-0C69-48E4-AAD5-6AB9F41EFE38Q30540433-4E8C8143-99F0-4707-928B-83D82D6C1162Q30583700-385AFB77-5E40-4025-A460-6535B4F3ACA4Q30606267-3C6E0305-7988-4D28-B895-D17B9ACCDA8AQ30992792-D1C08C79-2FA7-4A47-B28A-D8CA9E684741Q31016943-3CEAD1AB-CFCE-402E-80A8-0496DEAA46EEQ33286754-F0169357-CC24-45C1-A06B-2213070363BDQ33299493-3EBD03F5-A069-4E2D-B23B-D30EAF42D612Q33358839-E7B7392F-1573-417C-84D8-FD2F53A387D6Q33417652-74E8F664-7216-4EA0-B401-AB0DBFA4B5A0Q33614514-103AE6F9-357B-41DE-B50F-F541EA6FAE46Q33621090-878D576C-69DB-4C3F-B7A3-21ADD3A4D120Q33624690-5A8DA3C7-E4D4-4FC5-930D-5A8F8648A2B2
P2860
Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Efficient particle production ...... p2 and a late assembly domain.
@ast
Efficient particle production ...... p2 and a late assembly domain.
@en
type
label
Efficient particle production ...... p2 and a late assembly domain.
@ast
Efficient particle production ...... p2 and a late assembly domain.
@en
prefLabel
Efficient particle production ...... p2 and a late assembly domain.
@ast
Efficient particle production ...... p2 and a late assembly domain.
@en
P2093
P2860
P1433
P1476
Efficient particle production ...... p2 and a late assembly domain.
@en
P2093
H G Göttlinger
M A Accola
P2860
P304
P356
10.1128/JVI.74.12.5395-5402.2000
P577
2000-06-01T00:00:00Z